title: The clinical use of milnacipran for depression.
abstract: We examined the relation between dosage and efficacy, and the predictors of response to milnacipran. There was no difference between 50 and 100 mg dose. However, the 100 mg dose had a faster onset of action than the 50 mg dose. An age and an episode have been predictors of milnacipran.
authors.affiliation: Department of Psychiatry, Kawasaki Medical School, 577 Matsushima, Kurashiki-city, 701-0192 Okayama, Japan. morisita@med.kawaski-m.ac.jp
authors.forename: Shigeru
authors.initials: S
authors.lastname: Morishita
authors.forename: Seizaburo
authors.initials: S
authors.lastname: Arita
mesh_terms: D000328:Adult; D000367:Age Factors; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003521:Cyclopropanes / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D000078764:Milnacipran; D011569:Psychiatric Status Rating Scales; D011897:Random Allocation; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D003521:Cyclopropanes; D000078764:Milnacipran